Chen‐Hui Luo

550 total citations
32 papers, 423 citations indexed

About

Chen‐Hui Luo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chen‐Hui Luo has authored 32 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Chen‐Hui Luo's work include Pharmacogenetics and Drug Metabolism (5 papers), Cancer-related molecular mechanisms research (5 papers) and Hormonal Regulation and Hypertension (5 papers). Chen‐Hui Luo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Cancer-related molecular mechanisms research (5 papers) and Hormonal Regulation and Hypertension (5 papers). Chen‐Hui Luo collaborates with scholars based in China, United States and Thailand. Chen‐Hui Luo's co-authors include Wei Zhang, An Wang, Bangning Yu, Zhi Li, Hui Zhou, Gan Zhou, Hong‐Hao Zhou, Jie Tang, Zhi‐Rong Tan and Jie Liu and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Blood.

In The Last Decade

Chen‐Hui Luo

29 papers receiving 419 citations

Peers

Countries citing papers authored by Chen‐Hui Luo

Since Specialization

Citations

This map shows the geographic impact of Chen‐Hui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Hui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Hui Luo more than expected).

Fields of papers citing papers by Chen‐Hui Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Hui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Hui Luo. The network helps show where Chen‐Hui Luo may publish in the future.

Co-authorship network of co-authors of Chen‐Hui Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Hui Luo. A scholar is included among the top collaborators of Chen‐Hui Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Hui Luo. Chen‐Hui Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular Recognition Driven Organelle Cross‐Linking Induces Endoplasmic Reticulum Stress and Mitochondrial Dysfunction to Potentiate Cancer Immunotherapy 2025 ·Angewandte Chemie International Edition ·(unknown), Jianfeng Qiu, Yunfeng Lu, (unknown), Yin Liu, Chen‐Hui Luo, Chunhai Fan, Ruibing Wang	0
2	MicroRNA‐505‐3p mediates cell motility of epithelial ovarian cancer via suppressing PEAK1 expression 2024 ·Journal of Biochemical and Molecular Toxicology ·Yanni Wu, (unknown), Wei Xiong, Haiyang Li, Jiao Wu, Wei Xie, Ying Long, Ying Liu, Chen‐Hui Luo	0
3	CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma 2024 ·Nature Communications ·Chen‐Hui Luo, Lihong Hu, (unknown), Xia Li, Li Zhou, (unknown), Cindy Lin, Xing Qiu, Biao Jiang, (unknown), Xuehong Zhang, Xiaobao Yang, Guoqiang Chen, Ying Lu	2
4	let‐7g sensitized liver cancer cells to 5‐fluorouracil by downregulating ABCC10 expression 2023 ·Chemical Biology & Drug Design ·Yun Chen, Bocheng Zhang, (unknown), Yuqing Zhou, Lei Xue, Chen‐Hui Luo, Yi Liang, Qian Gong, Ying Long	2
5	Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells 2023 ·Cancer Research ·Xia Li, (unknown), (unknown), Xuehong Zhang, (unknown), Qianqian Yin, Chen‐Hui Luo, (unknown), (unknown), (unknown), (unknown), Aiwu Zhou, Haiyan Cai, Edmund K. Waller, Jinsong Yan, Ying Lu	4
6	Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicity 2023 ·Microbes and Infection ·(unknown), (unknown), Hui Yin, (unknown), Jiajia Cui, Ji‐Ye Yin, Chen‐Hui Luo, Chengxian Guo	8
7	A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma 2023 ·Journal of Translational Medicine ·(unknown), (unknown), (unknown), (unknown), Qi Xiao, Qiao‐Li Lv, Chen‐Hui Luo, Chengxian Guo, Jingao Li, Xiaoxue Xie, Ji‐Ye Yin	2
8	The association between outdoor air pollution and lung cancer risk in seven eastern metropolises of China: Trends in 2006-2014 and sex differences 2022 ·Frontiers in Oncology ·(unknown), Meng Liu, Zhe-Yu Hu, Xia Yuan, (unknown), Kunlun Li, (unknown), (unknown), Xiaofang Zhou, (unknown), Chen‐Hui Luo, Yi He, (unknown)	5
9	Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells 2022 ·Cell Death and Disease ·Jinsong Yan, (unknown), Xuehong Zhang, Chen‐Hui Luo, (unknown), Yue Jiang, (unknown), (unknown), Lixue Yang, (unknown), Xia Li, Ying Lu	15
10	lncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress 2021 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), (unknown), Le Chen, (unknown), Yun Zhang, Chen‐Hui Luo, Jie Tang	12
11	MicroRNA-2355-5p Promotes the Proliferation of Head and Neck Squamous Cell Carcinoma via Suppressing NISCH Expression 2021 ·Journal of Oncology ·Hailin Zhang, (unknown), (unknown), Bocheng Zhang, Mingjing Peng, Sha Li, Xiaowu Sheng, (unknown), Qian Gong, (unknown), Chen‐Hui Luo, Jie Dai, Xiao Zhou, Ying Long	1
12	High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer 2020 ·Cancer Cell International ·(unknown), (unknown), Le Chen, Ying Yao, Junjun Li, Yun Zhang, Chen‐Hui Luo, (unknown), Jie Tang	24
13	Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway 2018 ·Cellular Physiology and Biochemistry ·Yongbin Liu, Ying Mei, (unknown), Jing Long, Chen‐Hui Luo, Hong‐Hao Zhou	22
14	Overexpression of TRPM7 is Associated with Poor Prognosis in Human Ovarian Carcinoma 2014 ·Asian Pacific Journal of Cancer Prevention ·Jing Wang, Ling Xiao, Chen‐Hui Luo, Hui Zhou, (unknown), (unknown), (unknown), Yu Zhang	30
15	Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers 2014 ·Current Therapeutic Research ·Kunyan Li, Yu Qiu, Yun Jiang, Chen‐Hui Luo, (unknown), Jing Wang, Nong Yang	3
16	The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study 2010 ·Clinical Therapeutics ·Kunyan Li, Jianping Liang, (unknown), Yu Qiu, Chen‐Hui Luo, Yun Jiang, (unknown), Nong Yang	11
17	Effect of the CYP2C93 allele on lornoxicam metabolism 2005 ·Clinica Chimica Acta* ·Yali Liu, Wei Zhang, Zhi‐Rong Tan, Dongsheng Ouyang, Chen‐Hui Luo, Zhaoqian Liu, Yu Qiu, Yao Chen, Yijing He, Gan Zhou, Hong‐Hao Zhou	15
18	Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients 2005 ·European Journal of Clinical Pharmacology ·An Wang, Bangning Yu, Chen‐Hui Luo, Zhi‐Rong Tan, Gan Zhou, Liansheng Wang, Wei Zhang, Zhi Li, Jie Liu, Hong‐Hao Zhou	66
19	Gender specific association of CYP2C93* with hyperlipidaemia in Chinese 2005 ·British Journal of Clinical Pharmacology ·Chen‐Hui Luo, An Wang, Ronghua Zhu, (unknown), Wei Mo, Bangning Yu, Guo‐Lin Chen, Dongsheng Ouyang, Xiaohong Duan, A.M. Abd El‐Aty, Hong‐Hao Zhou	3
20	CYP2C9 allele variants in Chinese hypertension patients and healthy controls 2004 ·Clinica Chimica Acta ·Bangning Yu, Chen‐Hui Luo, Dan Wang, An Wang, Zhi Li, Wei Zhang, Wei Mo, Hong‐Hao Zhou	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact